Lupin Pharmaceuticals Inc. recalls Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Ma
Recalled October 27, 2021 · FDA recall D-0027-2022 · Lupin Pharmaceuticals
Hazard
Out of specification result observed in a dissolution test at the 9-month long term stability time point. · FDA Class II
Units
1,902 bottles
Sold at
Distributed Nationwide in the USA.
Description
Out of specification result observed in a dissolution test at the 9-month long term stability time point.
Product
Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 UNited States. Manufactured by: Lupin Limited, Pithampur, (M.P.) 454 775 India NDC# 68180-316-06
Manufacturer(s)
Lupin Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →